Geode Capital Management, LLC Collegium Pharmaceutical, Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 775,579 shares of COLL stock, worth $23.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

775,579

Previous 770,115 0.71%

Holding current value

$23.2 Million

Previous $24.8 Million 20.85%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.4 - $39.07 $171,569 - $213,478	5,464 Added 0.71%	775,579 $30 Million
Q2 2024 Aug 09, 2024	BUY	$31.36 - $39.99 $1.15 Million - $1.46 Million	36,567 Added 4.98%	770,115 $24.8 Million
Q1 2024 May 13, 2024	BUY	$31.23 - $40.91 $71,266 - $93,356	2,282 Added 0.31%	733,548 $28.5 Million
Q4 2023 Feb 13, 2024	BUY	$21.16 - $30.8 $431,283 - $627,765	20,382 Added 2.87%	731,266 $22.5 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $449,863 - $514,493	21,190 Added 3.07%	710,884 $15.9 Million
Q2 2023 Aug 11, 2023	BUY	$21.06 - $24.0 $979,416 - $1.12 Million	46,506 Added 7.23%	689,694 $14.8 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $558,233 - $725,217	24,271 Added 3.92%	643,188 $15.4 Million
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $213,451 - $311,448	13,225 Added 2.18%	618,917 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $35,650 - $46,350	2,306 Added 0.38%	605,692 $9.7 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $102,654 - $150,732	-7,219 Reduced 1.18%	603,386 $10.7 Million
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $94,049 - $123,030	5,468 Added 0.9%	610,605 $12.4 Million
Q4 2021 Feb 11, 2022	SELL	$17.5 - $21.35 $95,480 - $116,485	-5,456 Reduced 0.89%	605,137 $11.3 Million
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $206,059 - $294,752	-11,609 Reduced 1.87%	610,593 $12.1 Million
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $781,052 - $908,234	35,927 Added 6.13%	622,202 $14.7 Million
Q1 2021 May 12, 2021	BUY	$19.25 - $26.1 $1.17 Million - $1.58 Million	60,587 Added 11.53%	586,275 $13.9 Million
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $349,949 - $437,485	19,627 Added 3.88%	525,688 $10.5 Million
Q3 2020 Nov 13, 2020	SELL	$15.78 - $20.82 $30,013 - $39,599	-1,902 Reduced 0.37%	506,061 $10.5 Million
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $310,651 - $471,493	20,055 Added 4.11%	507,963 $8.89 Million
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $871,805 - $1.6 Million	62,765 Added 14.76%	487,908 $7.97 Million
Q4 2019 Feb 13, 2020	BUY	$10.7 - $22.24 $190,438 - $395,827	17,798 Added 4.37%	425,143 $8.75 Million
Q3 2019 Nov 12, 2019	BUY	$10.16 - $13.28 $45,323 - $59,242	4,461 Added 1.11%	407,345 $4.68 Million
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $422,123 - $659,419	39,748 Added 10.95%	402,884 $5.3 Million
Q1 2019 May 14, 2019	BUY	$13.58 - $18.72 $620,429 - $855,260	45,687 Added 14.39%	363,136 $5.5 Million
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $462,628 - $616,003	31,301 Added 10.94%	317,449 $5.45 Million
Q3 2018 Nov 13, 2018	BUY	$14.16 - $24.3 $845,960 - $1.45 Million	59,743 Added 26.39%	286,148 $4.22 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $546,841 - $709,965	25,096 Added 12.47%	226,405 $5.4 Million
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $175,601 - $282,606	9,675 Added 5.05%	201,309 $5.14 Million
Q4 2017 Feb 13, 2018	BUY	$9.3 - $19.14 $135,677 - $279,233	14,589 Added 8.24%	191,634 $3.54 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $60,170 - $78,714	6,576 Added 3.86%	177,045 $1.86 Million
Q2 2017 Aug 14, 2017	BUY	N/A	170,469	170,469 $2.13 Million

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Collegium Pharmaceutical, Inc Transaction History